{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:35:30Z","timestamp":1786995330073,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Project of Yunnan Provincial Department of Science and Technology and Kunming Medical University for Basic Research","award":["202301AY070001-162"],"award-info":[{"award-number":["202301AY070001-162"]}]},{"name":"Yunnan clinical medical center of nervous system diseases","award":["ZX2019-03-05"],"award-info":[{"award-number":["ZX2019-03-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10735-026-10902-3","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:33:38Z","timestamp":1783996418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["lncRNA MIR4435-2HG modulates the malignant progression of glioblastoma through the miR-181d-5p\/MALT1\/NF-\u03baB signaling pathway"],"prefix":"10.1007","volume":"57","author":[{"given":"Pei-sheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"1","key":"10902_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-020-03577-7","volume":"149","author":"E Butterbrod","year":"2020","unstructured":"Butterbrod E, Synhaeve N, Rutten GJ et al (2020) Cognitive impairment three months after surgery is an independent predictor of survival time in glioblastoma patients. J Neurooncol 149(1):103\u2013111","journal-title":"J Neurooncol"},{"issue":"14","key":"10902_CR2","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.7150\/thno.74600","volume":"12","author":"B Li","year":"2022","unstructured":"Li B, Zhao R, Qiu W et al (2022) The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. Theranostics 12(14):6363\u20136379","journal-title":"Theranostics"},{"issue":"3","key":"10902_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12264-022-00950-6","volume":"39","author":"Y Bai","year":"2023","unstructured":"Bai Y, Ren H, Bian L et al (2023) Regulation of glial function by noncoding RNA in central nervous system disease. Neurosci Bull 39(3):440\u2013452","journal-title":"Neurosci Bull"},{"issue":"1","key":"10902_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-022-02431-0","volume":"41","author":"Z Gao","year":"2022","unstructured":"Gao Z, Xu J, Fan Y et al (2022) PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C\/EBP\u03b2 degradation to facilitate proneural-to-mesenchymal transition. J Exp Clin Cancer Res 41(1):223","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10902_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13046-021-01928-4","volume":"40","author":"C Zhong","year":"2021","unstructured":"Zhong C, Yu Q, Peng Y et al (2021) Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195\/CDC25A axis in glioblastoma. J Exp Clin Cancer Res 40(1):123","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10902_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13046-022-02543-7","volume":"41","author":"D He","year":"2022","unstructured":"He D, Xin T, Pang B et al (2022) A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy. J Exp Clin Cancer Res 41(1):349","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"10902_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00109-018-1654-5","volume":"96","author":"H Qian","year":"2018","unstructured":"Qian H, Chen L, Huang J et al (2018) The lncRNA MIR4435-2HG promotes lung cancer progression by activating \u03b2-catenin signalling. J Mol Med (Berl) 96(8):753\u2013764","journal-title":"J Mol Med (Berl)"},{"issue":"17","key":"10902_CR8","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.18632\/aging.102164","volume":"11","author":"H Wang","year":"2019","unstructured":"Wang H, Wu M, Lu Y et al (2019) LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt\/\u03b2-catenin signaling. Aging 11(17):6657\u20136673","journal-title":"Aging"},{"key":"10902_CR9","doi-asserted-by":"publisher","first-page":"855078","DOI":"10.3389\/fimmu.2022.855078","volume":"13","author":"C Zhong","year":"2022","unstructured":"Zhong C, Xie Z, Zeng LH et al (2022) MIR4435-2HG Is a potential pan-cancer biomarker for diagnosis and prognosis. Front Immunol 13:855078","journal-title":"Front Immunol"},{"key":"10902_CR10","doi-asserted-by":"publisher","first-page":"160564","DOI":"10.1016\/j.scitotenv.2022.160564","volume":"861","author":"QF Lao","year":"2023","unstructured":"Lao QF, Zhang QQ, Qiao ZP et al (2023) Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells. Sci Total Environ 861:160564","journal-title":"Sci Total Environ"},{"issue":"2","key":"10902_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/genes14020290","volume":"14","author":"JB Liu","year":"2023","unstructured":"Liu JB, Zhang JB, Yan XM et al (2023) DNA double-strand break-related competitive endogenous RNA network of noncoding RNA in bovine cumulus cells. Genes (Basel) 14(2):290","journal-title":"Genes (Basel)"},{"key":"10902_CR12","doi-asserted-by":"publisher","first-page":"111801","DOI":"10.1016\/j.msec.2020.111801","volume":"121","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang Y, Cheng X et al (2021) MiR-181d-5p regulates implant surface roughness-induced osteogenic differentiation of bone marrow stem cells. Mater Sci Eng C Mater Biol Appl 121:111801","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10902_CR13","doi-asserted-by":"publisher","first-page":"707970","DOI":"10.3389\/fcell.2021.707970","volume":"9","author":"X Dong","year":"2021","unstructured":"Dong X, Liu Y, Deng X et al (2021) C1GALT1, negatively regulated by miR-181d-5p, promotes tumor progression via upregulating RAC1 in lung adenocarcinoma. Front Cell Dev Biol 9:707970","journal-title":"Front Cell Dev Biol"},{"key":"10902_CR14","doi-asserted-by":"publisher","first-page":"109217","DOI":"10.1016\/j.clim.2022.109217","volume":"248","author":"Q Li","year":"2023","unstructured":"Li Q, He J, Li S et al (2023) The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 \/ NF-\u03baB pathway. Clin Immunol 248:109217","journal-title":"Clin Immunol"},{"key":"10902_CR15","doi-asserted-by":"publisher","first-page":"875320","DOI":"10.3389\/fimmu.2022.875320","volume":"13","author":"S Biswas","year":"2022","unstructured":"Biswas S, Chalishazar A, Helou Y et al (2022) Pharmacological inhibition of MALT1 ameliorates autoimmune pathogenesis and can be uncoupled from effects on regulatory T-cells. Front Immunol 13:875320","journal-title":"Front Immunol"},{"issue":"3","key":"10902_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.30802\/AALAS-JAALAS-18-000094","volume":"58","author":"JW Dutton","year":"2019","unstructured":"Dutton JW 3rd, Artwohl JE, Huang X et al (2019) Assessment of pain associated with the injection of sodium pentobarbital in laboratory mice (Mus musculus). J Am Assoc Lab Anim Sci 58(3):373\u2013379","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10902_CR17","doi-asserted-by":"publisher","first-page":"156559","DOI":"10.1016\/j.phymed.2025.156559","volume":"140","author":"W Qi","year":"2025","unstructured":"Qi W, Cao X, Chen Y et al (2025) JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut-liver axis and lipid metabolism. Phytomedicine 140:156559","journal-title":"Phytomedicine"},{"issue":"11","key":"10902_CR18","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1111\/jcmm.15280","volume":"24","author":"H Xu","year":"2020","unstructured":"Xu H, Zhang B, Yang Y et al (2020) LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p\/TGFBR2 axis. J Cell Mol Med 24(11):6362\u20136372","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10902_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41418-020-00606-w","volume":"28","author":"J Ji","year":"2021","unstructured":"Ji J, Ding K, Luo T et al (2021) TRIM22 activates NF-\u03baB signaling in glioblastoma by accelerating the degradation of I\u03baB\u03b1. Cell Death Differ 28(1):367\u2013381","journal-title":"Cell Death Differ"},{"issue":"1","key":"10902_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-019-1073-4","volume":"18","author":"S Peng","year":"2019","unstructured":"Peng S, Wang R, Zhang X et al (2019) EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression. Mol Cancer 18(1):165","journal-title":"Mol Cancer"},{"issue":"2","key":"10902_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5603\/FHC.a2022.0018","volume":"60","author":"M Yu","year":"2022","unstructured":"Yu M, Yi Z, Chen S et al (2022) MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells. Folia Histochem Cytobiol 60(2):191\u2013202","journal-title":"Folia Histochem Cytobiol"},{"issue":"18","key":"10902_CR22","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1111\/febs.15233","volume":"287","author":"S Zhang","year":"2020","unstructured":"Zhang S, Li C, Liu J et al (2020) Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG\/miR-296-5p\/Akt2\/SNAI1 signaling pathway. Febs j 287(18):4032\u20134047","journal-title":"Febs j"},{"issue":"1","key":"10902_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3892\/mmr.2021.12554","volume":"25","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Li B, Xu G et al (2022) lncRNA MIR4435\u20132HG promotes the progression of liver cancer by upregulating B3GNT5 expression. Mol Med Rep 25(1):38","journal-title":"Mol Med Rep"},{"issue":"1","key":"10902_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41420-022-01219-7","volume":"8","author":"M Ding","year":"2022","unstructured":"Ding M, Zhao X, Chen X et al (2022) Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p. Cell Death Discov 8(1):439","journal-title":"Cell Death Discov"},{"key":"10902_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.omtn.2019.11.024","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H, Wei H, Wang J et al (2020) MicroRNA-181d-5p-containing exosomes derived from CAFs promote EMT by regulating CDX2\/HOXA5 in breast cancer. Mol Ther Nucleic Acids 19:654\u2013667","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10902_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/mc.23474","volume":"62","author":"M Liu","year":"2023","unstructured":"Liu M, Xue G, Liu R et al (2023) Saponin from platycodi radix inactivates PI3K\/AKT signaling pathway to hinder colorectal cancer cell proliferation, invasion, and migration through miR-181c\/d-5p\/RBM47. Mol Carcinog 62(2):174\u2013184","journal-title":"Mol Carcinog"},{"key":"10902_CR27","doi-asserted-by":"crossref","unstructured":"Jiang VC, Liu Y, Lian J et al (2023) Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma. J Clin Invest 133(3)","DOI":"10.1172\/JCI165694"},{"key":"10902_CR28","doi-asserted-by":"publisher","first-page":"845048","DOI":"10.3389\/fcell.2022.845048","volume":"10","author":"R Qian","year":"2022","unstructured":"Qian R, Niu X, Wang Y et al (2022) Targeting MALT1 suppresses the malignant progression of colorectal cancer via miR-375\/miR-365a-3p\/NF-\u03baB axis. Front Cell Dev Biol 10:845048","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10902_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10565-024-09888-z","volume":"40","author":"Y Wang","year":"2024","unstructured":"Wang Y, Deng X, Xie J et al (2024) The COP9 signalosome stabilized MALT1 promotes non-small cell lung cancer progression through activation of NF-\u03baB pathway. Cell Biol Toxicol 40(1):45","journal-title":"Cell Biol Toxicol"},{"issue":"15","key":"10902_CR30","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1182\/bloodadvances.2023012394","volume":"8","author":"Y Yao","year":"2024","unstructured":"Yao Y, Yuan M, Shi M et al (2024) Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-\u03baB and inducing immunogenic cell death. Blood Adv 8(15):4003\u20134016","journal-title":"Blood Adv"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10902-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:01:40Z","timestamp":1786993300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10902-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10902"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10902-3","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines and received approval from the Experimental Animal Ethics Committee of Yunnan Labreal Biotechnology Co., Ltd (PZ20220212). The Committee Ethics mandated that the tumor burden in mice remain below 10% of their body weight. Throughout the experimental period, no animal developed a tumor burden that exceeded this limit.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to publication was obtained by all the participants.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"229"}}